Skip to content

Ishrat Husain

3 papers in the library · 2 citations · publishing 2023-2025

Papers

Sort Most recent Most cited

Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging study

Alzheimer s & Dementia December 1, 2025 Danielle Bukovsky, Aron Amaev, Jianmeng Song et al.

Abstract Background Amnestic mild cognitive impairment (aMCI) is characterized by synaptic loss and cognitive decline and is considered a precursor to Alzheimer’s Disease. Currently, there are no effective treatments for aMCI, and available treatments (i.e., cholinesterase inhibitors) do not appear to improve cognitive or functional outcomes. Psychedelics, including psilocybin, have regained...

Mindfulness-based (non-contact) boxing therapy (MBBT) for depression and anxiety: A feasibility study.

PLoS One 2025 Johny Bozdarov, Brett D. M. Jones, Madeha Umer et al. 2 citations

Mindfulness-Based (non-contact) Boxing Therapy (MBBT) is a novel intervention designed to empower and promote self-agency through behavioral interventions, while reducing barriers to exercise for individuals with mental disorders. MBBT is an instructor-led, manualized, non-contact boxing group-exercise program (delivered in 90 min sessions, twice a week, over 10 weeks) that blends principles of...

Historical overview

March 1, 2023 Chase Thompson, Ishrat Husain

Abstract Humans have a long and complicated history with psychedelic compounds. Originally discovered as a component of certain plants and fungi, the psychedelics were widely used by ancient and indigenous peoples for millennia. Contemporary Western society had been largely disconnected from psychedelics but was reintroduced when Albert Hofmann first synthesized D-lysergic acid diethylamide...